Works by Schoenfeld, Adam J.

Results: 12
    1
    2
    3
    4
    5
    6
    7

    Impact of TMB/PD-L1 expression and pneumonitis on chemoradiation and durvalumab response in stage III NSCLC.

    Published in:
    Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-39874-8
    By:
    • Alessi, Joao V.;
    • Ricciuti, Biagio;
    • Wang, Xinan;
    • Pecci, Federica;
    • Di Federico, Alessandro;
    • Lamberti, Giuseppe;
    • Elkrief, Arielle;
    • Rodig, Scott J.;
    • Lebow, Emily S.;
    • Eicholz, Jordan E.;
    • Thor, Maria;
    • Rimner, Andreas;
    • Schoenfeld, Adam J.;
    • Chaft, Jamie E.;
    • Johnson, Bruce E.;
    • Gomez, Daniel R.;
    • Awad, Mark M.;
    • Shaverdian, Narek
    Publication type:
    Article
    8
    9

    Analysis of Tumor Mutational Burden, Progression-Free Survival, and Local-Regional Control in Patents with Locally Advanced Non–Small Cell Lung Cancer Treated With Chemoradiation and Durvalumab.

    Published in:
    JAMA Network Open, 2023, v. 6, n. 1, p. e2249591, doi. 10.1001/jamanetworkopen.2022.49591
    By:
    • Lebow, Emily S.;
    • Shepherd, Annemarie;
    • Eichholz, Jordan E.;
    • Offin, Michael;
    • Gelblum, Daphna Y.;
    • Wu, Abraham J.;
    • Simone II, Charles B.;
    • Schoenfeld, Adam J.;
    • Jones, David R.;
    • Rimner, Andreas;
    • Chaft, Jamie E.;
    • Riaz, Nadeem;
    • Gomez, Daniel R.;
    • Shaverdian, Narek
    Publication type:
    Article
    10

    Identification of optimal dosing schedules of dacomitinib and osimertinib for a phase I/II trial in advanced EGFR-mutant non-small cell lung cancer.

    Published in:
    Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-23912-4
    By:
    • Poels, Kamrine E.;
    • Schoenfeld, Adam J.;
    • Makhnin, Alex;
    • Tobi, Yosef;
    • Wang, Yuli;
    • Frisco-Cabanos, Heidie;
    • Chakrabarti, Shaon;
    • Shi, Manli;
    • Napoli, Chelsi;
    • McDonald, Thomas O.;
    • Tan, Weiwei;
    • Hata, Aaron;
    • Weinrich, Scott L.;
    • Yu, Helena A.;
    • Michor, Franziska
    Publication type:
    Article
    11

    Outcomes of Combination Platinum-Doublet Chemotherapy and Anti-PD(L)-1 Blockade in KRAS<sup>G12C</sup>-Mutant Non-Small Cell Lung Cancer.

    Published in:
    Oncologist, 2023, v. 28, n. 11, p. 978, doi. 10.1093/oncolo/oyad197
    By:
    • Elkrief, Arielle;
    • Riccuiti, Biagio;
    • Alessi, Joao V;
    • Fei, Teng;
    • Kalvin, Hannah L;
    • Egger, Jacklynn V;
    • Rizvi, Hira;
    • Thummalapalli, Rohit;
    • Lamberti, Guiseppe;
    • Plodkowski, Andrew;
    • Hellmann, Matthew D;
    • Kris, Mark G;
    • Arcila, Maria E;
    • Baine, Marina K;
    • Rudin, Charles M;
    • Lito, Piro;
    • Ladanyi, Marc;
    • Schoenfeld, Adam J;
    • Riely, Gregory J;
    • Awad, Mark M
    Publication type:
    Article
    12

    A clinical benchmark of public self-supervised pathology foundation models.

    Published in:
    Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-025-58796-1
    By:
    • Campanella, Gabriele;
    • Chen, Shengjia;
    • Singh, Manbir;
    • Verma, Ruchika;
    • Muehlstedt, Silke;
    • Zeng, Jennifer;
    • Stock, Aryeh;
    • Croken, Matt;
    • Veremis, Brandon;
    • Elmas, Abdulkadir;
    • Shujski, Ivan;
    • Neittaanmäki, Noora;
    • Huang, Kuan-lin;
    • Kwan, Ricky;
    • Houldsworth, Jane;
    • Schoenfeld, Adam J.;
    • Vanderbilt, Chad
    Publication type:
    Article